Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Cytos Biotechnology AG

+ Add to Watchlist

CSBTF:US

Snapshot for Cytos Biotechnology AG (CSBTF)

Open: - Day's Range: - Volume: 0
Previous Close: 0.2520 52wk Range: 0.1589 - 3.7600 1-Yr Rtn: -

Stock Chart for CSBTF

No chart data available.
  • CSBTF:US 0.2520
  • 1M
  • 1Y
0.2520
Interactive CSBTF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CSBTF

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (CHF) (ttm) -
Est. EPS (CHF) (12/2014) -0.9150
Est. PEG Ratio -
Market Cap (M USD) 0.00
Shares Outstanding (M) 30.53
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CSBTF

  • Revenue
  • Net Income (M/CHF)
  • Profit Margin (%)

Company Profile & Key Executives for CSBTF

Cytos Biotechnology AG develops and produces biopharmaceuticals. The Company produces vaccines that immunize the patient against disease related proteins. This instructs the immune system to produce antibodies to reverse or prevent disease progression. Cytos develops treatments for immunology and inflammation disorders, cancer and cardiovascular, nervous system, and infectious diseases.

Christian ItinChairman/CEOHarry WeltenExec VP/CFO
Frank HenneckeExec VP:Product DevDorothee KrumwiehVice President
More Company Profile & Key Executives for CSBTF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil